Compounds > angiotensin ii
Page last updated: 2024-08-22

angiotensin ii and Autosomal Dominant Juvenile Parkinson Disease

angiotensin ii has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Franco, R; Labandeira-García, JL; Lillo, J; Muñoz, A; Navarro, G; Rivas-Santisteban, R; Rodríguez-Pérez, AI1
Ahmadi, F; Fariss, MW; Grammatopoulos, TN; Jones, SM; Weyhenmeyer, JA; Zawada, WM1
Guerra, MJ; Labandeira-Garcia, JL; Muñoz, A; Parga, JA; Rey, P; Rodriguez-Pallares, J1

Other Studies

3 other study(ies) available for angiotensin ii and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Novel Interactions Involving the Mas Receptor Show Potential of the Renin-Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia.
    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2021, Volume: 18, Issue:2

    Topics: Angiotensin II; Animals; Corpus Striatum; Dyskinesia, Drug-Induced; HEK293 Cells; Humans; Male; Mice; Mice, Inbred C57BL; Microglia; Oxidopamine; Parkinsonian Disorders; Proto-Oncogene Mas; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System

2021
Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death.
    Brain research, 2005, May-31, Volume: 1045, Issue:1-2

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Cell Death; Cells, Cultured; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Antagonists; Insecticides; Losartan; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Oxidative Stress; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Rotenone; Substantia Nigra; Tyrosine 3-Monooxygenase

2005
Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS.
    Neurobiology of disease, 2008, Volume: 31, Issue:1

    Topics: Adrenergic Agents; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Brain; Cells, Cultured; Dopamine; Fluorescent Antibody Technique; Immunohistochemistry; Microglia; NADP; Nerve Degeneration; Neurons; Oxidopamine; Parkinsonian Disorders; Rats; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction

2008